Today's Veterinary Practice

SEP-OCT 2018

Today's Veterinary Practice provides comprehensive information to keep every small animal practitioner up to date on companion animal medicine and surgery as well as practice building and management.

Issue link: https://todaysveterinarypractice.epubxp.com/i/1015043

Contents of this Issue

Navigation

Page 79 of 79

IMPORTANT SAFETY INFORMATION: NexGard is for use in dogs only. The most frequently reported adverse reactions include vomiting, pruritus, lethargy, diarrhea and lack of appetite. The safe use of NexGard in pregnant, breeding, or lactating dogs has not been evaluated. Use with caution in dogs with a history of seizures or neurologic disorders. For more information, see the full prescribing information or visit www.NexGardForDogs.com. NexGard ® is a registered trademark, and FRONTLINE VET LABS TM is a trademark, of Merial. ©2018 Merial, Inc., Duluth, GA. All rights reserved. PET-0691-NEX0818. NexGard is a Merial product. Merial is now part of Boehringer Ingelheim. 1 Data on fi le. Take a bite out of Lyme. NexGard® (afoxolaner) is the ONLY chew that combines all of the following benefi ts into the one that dogs prefer 1 : ✓ Kills fl eas ✓ Kills ticks — lone star ticks, brown dog ticks, American dog ticks, and black-legged (deer) ticks ✓ And FDA-approved for the prevention of Borrelia burgdorferi infections as a direct result of killing Ixodes scapularis vector ticks

Articles in this issue

Links on this page

Archives of this issue

view archives of Today's Veterinary Practice - SEP-OCT 2018